Grant Novartis Ag Transaction History

Grant

$201 Million
Q3 2024

A detailed history of Grant transactions in Novartis Ag stock. As of the latest transaction made, Grant holds 3,189 shares of NVS stock, worth $313,797. This represents 0.18% of its overall portfolio holdings.

Number of Shares

3,189

Previous 3,210 0.65%

Holding current value

$313,797

Previous $341,000 7.33%

% of portfolio

0.18%

Previous 0.18%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$106.13 - $120.89 $2,228 - $2,538	-21 Reduced 0.65%	3,189 $366,000
Q2 2024 Jul 22, 2024	SELL	$92.57 - $107.37 $75,444 - $87,506	-815 Reduced 20.25%	3,210 $341,000
Q1 2024 Apr 25, 2024	SELL	$95.27 - $108.47 $285,810 - $325,410	-3,000 Reduced 42.7%	4,025 $389,000
Q2 2023 Jul 19, 2023	BUY	$92.52 - $104.91 $649,953 - $736,992	7,025 New	7,025 $708,000
Q3 2022 Nov 02, 2022	BUY	$74.61 - $87.26 $176,900 - $206,893	2,371 Added 50.95%	7,025 $551,000
Q1 2022 Apr 25, 2022	BUY	$80.11 - $90.62 $372,831 - $421,745	4,654 New	4,654 $426,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.

Account